Statins increase risk of hemorrhagic stroke by inhibition of the PAR-1 receptor

被引：15
|
作者：
Serebruany, Victor L.
Malinin, Alex I.
Hennekens, Charles H.
机构：
[1] Johns Hopkins Univ, HeartDrug TM Res Labs, Baltimore, MD USA
[2] Univ Miami, Miller Sch Med, Boca Raton, FL USA
[3] Florida Atlantic Univ, Boca Raton, FL 33431 USA
来源：
CEREBROVASCULAR DISEASES | 2007年 / 24卷 / 05期
关键词：
D O I：
10.1159/000108923
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：477 / 479
页数：3
相关论文
共 50 条
  • [1] Statins inhibit platelet PAR-1 receptors: The PAR-1 inhibition by statins (PARIS) trial
    Serebruany, V
    Miller, M
    Malinin, A
    Pokov, A
    Lowry, D
    Hennekens, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 4H - 4H
  • [2] Statins inhibit platelet PAR-1 receptors: The PAR-1 inhibition by statins (PARIS) trial
    Serebruany, V
    Miller, M
    Malinin, A
    Pokov, A
    Lowry, D
    Hennekens, C
    [J]. CIRCULATION, 2005, 112 (17) : U727 - U727
  • [3] Statins inhibit platelet PAR-1 receptors: the PAR-1 inhibition by statins (PARIS) trial
    Serebruany, V. L.
    Miller, M.
    Malinin, A.
    Pokov, A.
    Lowry, D.
    Hennekens, C. H.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 581 - 581
  • [4] Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study)
    Serebruany, Victor L.
    Miller, Michael
    Pokov, Alex N.
    Malinin, Alex I.
    Lowry, David R.
    Tanguay, Jean-Francois
    Hennekens, Charles H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (09): : 1332 - 1336
  • [5] Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation
    Lyden, Patrick D.
    Pryor, Kent E.
    Minigh, Jennifer
    Davis, Thomas P.
    Griffin, John H.
    Levy, Howard
    Zlokovic, Berislav V.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [6] Promises of PAR-1 Inhibition in Acute Coronary Syndrome
    Sergio Leonardi
    Pierluigi Tricoci
    Kenneth W. Mahaffey
    [J]. Current Cardiology Reports, 2012, 14 : 32 - 39
  • [7] Promises of PAR-1 Inhibition in Acute Coronary Syndrome
    Leonardi, Sergio
    Tricoci, Pierluigi
    Mahaffey, Kenneth W.
    [J]. CURRENT CARDIOLOGY REPORTS, 2012, 14 (01) : 32 - 39
  • [8] Statins and HMGCR inhibition increase risk of diabetes
    [J]. Reactions Weekly, 2014, 1521 (1) : 12 - 12
  • [9] PAR-1 and PAR-2 receptor mediated actions in the human intestine
    Mueller, K.
    Michel, K.
    Krueger, D.
    Demir, I. E.
    Ceyhan, G. O.
    Zeller, F.
    Kreis, M. E.
    Schemann, M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 : 16 - 16
  • [10] Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
    Damiano, BP
    Cheung, WM
    Santulli, RJ
    Fung-Leung, WP
    Ngo, K
    Ye, RD
    Darrow, AL
    Derian, CK
    De Garavilla, L
    Andrade-Gordon, P
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (02): : 671 - 678
12345